# OnCo record nucleix (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/nucleix/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "nucleix" ;
  schema:name "Nucleix"@en ;
  schema:description "Nucleix makes urine and blood tests that read chemical marks on DNA to spot bladder cancer coming back and, in development, to find lung cancer early."@en ;
  schema:url <https://onco.cc/companies/nucleix/>, <https://nucleix.com/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://nucleix.com/>, <https://nucleix.com/wp-content/uploads/2023/05/PR_Nucleix_Bladder-EpiCheck-FDA-Clearance.pdf>, <https://nucleix.com/blog/news_and_events/nucleix-secures-55-million-funding-led-by-ra-capital-management-and-additional-prominent-life-science-investors-to-advance-lung-epicheck-for-early-detection-of-lung-cancer/> ;
  schema:addressCountry "IL" ;
  onco:cancers <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/nsclc/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/>, <https://onco.cc/fronts/early-detection/> ;
  onco:technologies <https://onco.cc/technologies/methylation-profiling/>, <https://onco.cc/technologies/liquid-biopsy/> .